Terms: = Prostate cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Treatment
446 results:
1. minor impact of anastomotic leakage in anterior resection for rectal cancer on long-term male urinary and sexual function.
Rutegård M; Jutesten H; Buchwald P; Angenete E; Lydrup ML
Int J Colorectal Dis; 2024 Apr; 39(1):49. PubMed ID: 38589520
[TBL] [Abstract] [Full Text] [Related]
2. Oncocytoid Salivary Tumors: Differential Diagnosis and Utility of Newly Described Immunohistochemistry.
Katabi N
Head Neck Pathol; 2024 Mar; 18(1):20. PubMed ID: 38502259
[TBL] [Abstract] [Full Text] [Related]
3. Evaluating the relationship between contouring variability and modelled treatment outcome for prostate bed radiotherapy.
Le Bao V; Haworth A; Dowling J; Walker A; Arumugam S; Jameson M; Chlap P; Wiltshire K; Keats S; Cloak K; Sidhom M; Kneebone A; Holloway L
Phys Med Biol; 2024 Apr; 69(8):. PubMed ID: 38471173
[No Abstract] [Full Text] [Related]
4. Comparing prostatic artery embolization to surgical and minimally invasive procedures for the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis.
Altman R; Ferreira R; Barragan C; Bhojani N; Lajkosz K; Zorn KC; Chughtai B; Annamalai G; Elterman DS
BMC Urol; 2024 Jan; 24(1):22. PubMed ID: 38281906
[TBL] [Abstract] [Full Text] [Related]
5. Novel Biodistribution of PSMA Radiotracer in the Uvula of Patients Undergoing PSMA PET/CT.
Philbrook P; Casano KR; Lee DJ
Clin Nucl Med; 2024 Feb; 49(2):e80-e81. PubMed ID: 38049963
[TBL] [Abstract] [Full Text] [Related]
6. In vitro and in vivo pharmacokinetics, disposition, and drug-drug interaction potential of tinengotinib (TT-00420), a promising investigational drug for treatment of cholangiocarcinoma and other solid tumors.
Ni S; Li L; Sun X; Wang Y; Yu Q; Wang W; Gu Z; Yu Z; Wu D; Wu F; Jiang S; Peng P
Eur J Pharm Sci; 2024 Jan; 192():106658. PubMed ID: 38048851
[TBL] [Abstract] [Full Text] [Related]
7. A comparison of aerobic- and resistance-emphasised exercise on cardiometabolic health and quality of life in men receiving androgen deprivation therapy for prostate cancer: Protocol for a feasibility trial.
Murphy K; Kehoe B; Denieffe S; Hacking D; Fairman CM; Harrison M
Contemp Clin Trials; 2024 Jan; 136():107388. PubMed ID: 37972755
[TBL] [Abstract] [Full Text] [Related]
8. Nanopore-related cellular death through cytoskeleton depolymerization by drug-induced ROS.
Zhang Y; Xu R; Wu J; Zhang Z; Wang Y; Yang H; Zhang S
Talanta; 2024 Feb; 268(Pt 2):125355. PubMed ID: 37952317
[TBL] [Abstract] [Full Text] [Related]
9. RP11-495P10.1 promotes HCC cell proliferation by regulating reprogramming of glucose metabolism and acetylation of the nr4a3 promoter via the PDK1/PDH axis.
Liu C; Shi J; Jiang Z; Jiang S; Wu Y; Peng D; Tang J; Guo L
Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):44-53. PubMed ID: 37905340
[TBL] [Abstract] [Full Text] [Related]
10. Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors.
Orozco-Moreno M; Visser EA; Hodgson K; Hipgrave Ederveen AL; Bastian K; Goode EA; Öztürk Ö; Pijnenborg JFA; Eerden N; Moons SJ; Rossing E; Wang N; de Haan N; Büll C; Boltje TJ; Munkley J
Glycobiology; 2023 Dec; 33(12):1155-1171. PubMed ID: 37847613
[TBL] [Abstract] [Full Text] [Related]
11. Photoactivation of pheophorbide-a utilizing 670 nm LEDs elicits cancer suppressive effects in androgen-independent prostate cancer cellular models.
Gheewala T; Ali Hussein M; Munirathinam G
J Pharm Pharmacol; 2023 Dec; 75(12):1544-1559. PubMed ID: 37823699
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of clinical outcomes among cancer patients treated in and out of clinical trials.
Duenas JAC; Sanchez P N; Bonilla CE
BMC Cancer; 2023 Aug; 23(1):786. PubMed ID: 37612602
[TBL] [Abstract] [Full Text] [Related]
13. A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active cancer.
Cohen AT; Wallenhorst C; Choudhuri S; Nassar A; Pollock KG; Martinez C
Thromb Haemost; 2024 Apr; 124(4):324-336. PubMed ID: 37527782
[TBL] [Abstract] [Full Text] [Related]
14. Per-fraction planning to enhance optimization degrees of freedom compared to the conventional single-plan approach.
Rossi L; Breedveld S; Heijmen B
Phys Med Biol; 2023 Aug; 68(17):. PubMed ID: 37524087
[No Abstract] [Full Text] [Related]
15. High-dose-rate brachytherapy as monotherapy versus as boost in unfavorable intermediate-risk localized prostate cancer: A matched-pair analysis.
Willen BD; Salari K; Zureick AH; Lang D; Ye H; Marvin K; Nandalur SR; Krauss DJ
Brachytherapy; 2023; 22(5):571-579. PubMed ID: 37328337
[TBL] [Abstract] [Full Text] [Related]
16. Selective ablation of TRA-1-60
White JM; Ramos N; Saliganan AD; Chung JY; Bell M; Lindquist J; Conner K; Wiesend WN; Schopperle M; Patrick SM; Kim S; Heath EI; Escorcia FE; Viola NT
Theranostics; 2023; 13(7):2057-2071. PubMed ID: 37153742
[No Abstract] [Full Text] [Related]
17. Parametric delineation uncertainties contouring (PDUC) modeling on CT scans of prostate cancer patients.
Ly V; Liu L; Cardenas C; Maroongroge S; De B; Basha DE; Court L; Luo X
J Appl Clin Med Phys; 2023 Jul; 24(7):e13970. PubMed ID: 37078392
[TBL] [Abstract] [Full Text] [Related]
18. Simultaneous hernia repair following robotic-assisted radical prostatectomy is safe with low rates of mesh-related complications.
Jaber AR; Moschovas MC; Rogers T; Saikali S; Perera R; Loy DG; Sandri M; Roof S; Diaz K; Ortiz C; Patel V
J Robot Surg; 2023 Aug; 17(4):1653-1658. PubMed ID: 36947293
[TBL] [Abstract] [Full Text] [Related]
19. Routine practice data of three cancer entities: Comparison among cancer registry and health insurance data.
Lang LM; Behr C; Ludwig M; Walker J; Christian Lange H; Basedow F; Justenhoven C
Z Evid Fortbild Qual Gesundhwes; 2023 Apr; 177():65-72. PubMed ID: 36804770
[TBL] [Abstract] [Full Text] [Related]
20. Outcomes of gracilis muscle interposition for rectourethral fistulas caused by treatment of prostate cancer.
Emile SH; Horesh N; Strassmann V; Garoufalia Z; Gefen R; Zhou P; Ray-Offor E; Dasilva G; Wexner SD
Tech Coloproctol; 2023 Oct; 27(10):937-944. PubMed ID: 36800073
[TBL] [Abstract] [Full Text] [Related]
[Next]
